Neuroleptic management of schizophrenia: A survey and commentary on Australian psychiatric practice

Parker, G, Lambert, T, McGrath, J, McGorry, P and Tiller, J (1998) Neuroleptic management of schizophrenia: A survey and commentary on Australian psychiatric practice. Australian And New Zealand Journal of Psychiatry, 32 1: 50-58. doi:10.3109/00048679809062705


Author Parker, G
Lambert, T
McGrath, J
McGorry, P
Tiller, J
Title Neuroleptic management of schizophrenia: A survey and commentary on Australian psychiatric practice
Journal name Australian And New Zealand Journal of Psychiatry   Check publisher's open access policy
ISSN 0004-8674
Publication date 1998-01-01
Sub-type Article (original research)
DOI 10.3109/00048679809062705
Volume 32
Issue 1
Start page 50
End page 58
Total pages 9
Language eng
Abstract Objective: We seek to assess Australian psychiatrists' views and practices concerning provision of neuroleptic medication to patients with schizophrenia, and to determine whether such management strategies are likely to have changed over time and the extent to which they correspond to published treatment guidelines. Method: A sample of 139 psychiatrists based in three Australian capital cities was derived, with respondents completing a brief questionnaire by choosing from a limited-option answer set. Co-authors of this paper comment on the extent to which responses are in line with contemporary recommendations driven by experts or empirical studies. Results: Overall, survey findings indicate that there has been considerable change in clinical practice over the last decade and provide some estimate of the extent to which Australian management practices are congruent with contemporary recommendations. We identify a number of issues of concern (more in relation to dose levels of neuroleptic medication rather than treatment duration) revealed by survey data and make recommendations for addressing a number of practical clinical issues. Conclusions: As this report focuses on central issues involved in managing schizophrenia, and integrates a number of treatment guidelines, we suggest that it should be of assistance for practice review by clinicians.
Keyword Psychiatry
Neuroleptic Treatment
Schizophrenia
Treatment Guidelines
Clinical-trials
Maintenance
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 9 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Mon, 13 Aug 2007, 20:22:31 EST